Alpha Crest Capital Management LLC Medpace Holdings, Inc. Transaction History

Alpha Crest Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $22,640 - $28,468	156 Added 4.11%	3,950 $621,000
Q2 2022 Aug 11, 2022	BUY	$130.2 - $168.03 $71,349 - $92,080	548 Added 16.88%	3,794 $568,000
Q1 2022 May 12, 2022	SELL	$138.87 - $214.31 $131,509 - $202,951	-947 Reduced 22.59%	3,246 $531,000
Q4 2021 Feb 09, 2022	BUY	$182.74 - $227.9 $565,214 - $704,894	3,093 Added 281.18%	4,193 $913,000
Q3 2021 Nov 10, 2021	SELL	$170.18 - $198.21 $374,396 - $436,062	-2,200 Reduced 66.67%	1,100 $208,000
Q2 2021 Aug 12, 2021	BUY	$158.62 - $194.3 $301,378 - $369,170	1,900 Added 135.71%	3,300 $583,000
Q1 2021 May 13, 2021	BUY	$132.02 - $168.26 $184,828 - $235,564	1,400 New	1,400 $230,000
Q4 2019 Feb 12, 2020	SELL	$70.08 - $84.64 $301,344 - $363,952	-4,300 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.38 - $85.89 $268,234 - $369,327	4,300 New	4,300 $361,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.